Skip to main content

Table 1 Genotype and allele distributions for each SNP between the patients with schizophrenia and healthy subjects

From: The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia

SNP IDs Gene Chr Risk Genotype frequencies Risk allele Allelic OR
allele +/+ +/- -/- +/+ +/- -/- frequencies p value (95% CI)
    +/- SCZ (n = 173) CON (n = 449) SCZ CON (χ2)
rs10503253 CSMD1 8p23.2 A/C 0.06 0.46 0.49 0.09 0.46 0.45 0.29 0.32 0.22 (1.5) 1.19 (0.90-1.56)
rs7004633 MMP16 8q21.3 G/A 0.03 0.37 0.60 0.06 0.36 0.57 0.21 0.25 0.24 (1.4) 1.20 (0.89-1.61)
rs7914558 CNNM2 10q24.32 G/A 0.23 0.53 0.24 0.29 0.49 0.22 0.49 0.53 0.23 (1.4) 1.16 (0.91-1.49)
rs11191580 NT5C2 10q24.33 T/C 0.49 0.42 0.09 0.50 0.42 0.07 0.70 0.72 0.55 (0.4) 1.09 (0.83-1.43)
rs12966547 CCDC68 18q21 G/A 0.15 0.44 0.41 0.17 0.44 0.39 0.37 0.39 0.54 (0.4) 1.09 (0.84-1.41)
  1. Abbreviations: Chr Chromosome; SCZ patients with schizophrenia; CON healthy controls; +, risk allele; -, non-risk allele; OR odds ratio.
  2. For alleles, the first allele is the risk allele. All risk alleles are represented based on the previous GWAS [7].